Sutro Biopharma, Inc. engages in the drug discovery, development and manufacture of pharmaceutical products. It focuses on the next generation cancer and autoimmune therapeutics. The company was founded by James R. Swartz and Sutanto Widjaja on April 21, 2003 and is headquartered in South San Francisco, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
137
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Sutro Biopharma Inc market cap is $142.77M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Sutro Biopharma Inc 52 week high is $43.85 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Sutro Biopharma Inc 52 week low is $7.15 as of November 22, 2026.
Sutro Biopharma Inc stock price today is $8.60.
Sutro Biopharma Inc stock price yesterday was $8.72.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Sutro Biopharma Inc's P/E ratio is -0.68.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Sutro Biopharma Inc P/B ratio is -1.0771.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Sutro Biopharma Inc 50-day moving average is $12.22.